Establishing a correlation between in vitro tests and in vivo product performance has always been a challenge for the pharmaceutical industry.  Without a link between specifications and in vivo performance, drug product manufacturing processes are often performed under unnecessarily tight controls. Furthermore, implementing changes post-product market approval can be challenging in a complex global environment.  This webinar will describe traditional and novel approaches towards establishing in vitro in vivo correlations. The main focus will be on solid oral dosage forms, however other dosage forms will also be discussed.

Moderators:
-Andreas Abend, Senior Principal Scientist, MSD, USA
-Horst-Dieter Friedel, FIP Chair Special Interest Group Regulatory Sciences and Quality, Germany

Panelist:
-Patrick Marroum, Senior Director in Clinical Pharmacology and Pharmacometrics AbbVie, USA

At this event on World Cancer Day, we will explore innovations in pharmacy practice in the community and hospital pharmacy settings, in terms of supporting cancer patients throughout their journey. A panel of experts will present and discuss examples of innovative professional services in cancer prevention and screening, access to cancer treatments, adherence and continuity across transitions of care, among others.

The goal is to raise awareness of the important role that pharmacists can play in all areas of practice in terms of cancer prevention and management, in collaboration with other healthcare professionals.

Learning Objectives

• Identify and discuss the roles that community and hospital pharmacists can play in cancer prevention and management.
• Present examples of best practices of cancer-related professional services by pharmacists from around the world.
• Discuss the importance of supporting patients in a multi- and inter-professional approach
• Explore issues on the transitions of care, adherence to treatments and prevention and screening in cancer care

Moderators:
• Josep M. Guiu Segura, Director of Pharmacy and Medicines, Consortium of Health and Social Care of Catalonia, Spain
• Daragh Connolly, President, FIP Community Pharmacy Section, Ireland

Panelists:
• Marko Skelin M.Pharm PhD. Board member of the European Society of Oncology Pharmacy; Assistant Professor, Faculty of Medicine, University of Rijeka, Croatia
• Robert Duncombe, Chief Pharmacist, Director of Pharmacy, The Christie NHS Foundation Trust, Manchester, UK
• Jan de Belie, Professional Affairs Advisor, Pharmaceutical Group of the European Union, Belgium
• Kofi Boamah Mensah, Oncology Pharmacist at Komfo Anokye Teaching Hospital (KATH) and adjunct lecturer at the Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Science, Kwame Nkrumah University of Science and Technology (KNUST), Ghana

Malaria is responsible for approximately 400 thousand deaths annually, resulting in an enormous public health burden on many of the tropical and subtropical countries. Although projects are ongoing in WHO, pharmaceutical companies and foundations, basic university-based research is also essential against for treatment and drug resistance in malaria. Engagement of young pharmaceutical scientists in the field is necessary to overcome this situation.

In this event, young PI and early carrier scientists / PhD students related to this scientific subject will be invited as speaker. Dr Eizo Takashima, Ehime University, Japan was invited as a speaker for preliminary lecture, and provide opportunity for young scientists to discuss about the science of malaria.

Learning objectives:

• Describe the development of malaria vaccine candidates.
• Defineseroepidemiology of malaria
• Recognize how early carrier pharmaceutical scientists can be involved in research on drug and vaccine development of malaria.

Moderators:
- Takuya Kumamoto, SIG NM Chair, Prof Hiroshima University, Japan
- Rebecka Isaksson, NGPS SIG Chair, Postdoctoral Research Associate UCL Department of Chemistry, UK

Panelists:
- Dr Eizo Takashima,Associate Professor, Ehime University, Japan
- Dr Wei-Chiao Huang, Post-doc State University of New York at Buffalo, US
- Dr Takaya Sakura, Assistant Professor Department of Molecular Infection Dynamics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Japan
- Khalid Garba Mohammed, Lecturer, Bayero University, Kano, Nigeria

The CPS Champion for Change 2021, Dr Odhiambo David, will share his vision on how pharmacists can better serve patients with mental health issues:
- Describe what service pharmacies should offer patients and/or healthcare systems to help tackle the mental health burden;
- In what ways can pharmacists support self-care and mental health patients having a more autonomous life; and
- How can digital health tools (either low or high tech) help community pharmacists improve outcomes and better support patients with mental health problems

EAHP, the European Association of Hospital Pharmacists, is pleased to invite you to our 2022 Annual Congress (https://www.eahp.eu/congresses), taking place from 23 to 25 March 2022 in Vienna, Austria.

"Hospital pharmacists – changing roles in a changing world" will be the theme for the presentations at our upcoming Congress in Vienna. During last year's virtual congress, we focused on digitalization and automation to improve future patient care. These new technologies found their way in to your daily practice or at least gave you inspiration for new projects. But these changes go beyond the hospital pharmacy and even beyond the hospital and healthcare; the whole world is evolving quickly which results in new needs and expectations from society. This year we will help you to determine and to explore the changing roles of hospital pharmacists in this evolving scene. This is an invitation to all of you to join us.

The EAHP team (https://www.eahp.eu/)

 Furthermore, the EAHP Congress is also an ideal time and place where to meet our colleagues, exchange our experience and find new professional connections and friends. Don't miss the opportunity!

Come to the 2022 FIP congress in Seville, Spain, where pharmacy practitioners, pharmaceutical scientists and educators from around the world will discuss and help you prepare for these new technologies that will empower our profession.

Previous industrial revolutions liberated humans from reliance on animal power, made mass production possible and brought digital capabilities to billions. This latest industrial revolution is, however, fundamentally different. It is characterised by a range of technologies that are fusing the physical, digital and biological worlds, impacting on all disciplines, economies and industries, and even challenging ideas about what it means to be human.

Digitalisation is already allowing the keeping of structured patient records, facilitating electronic prescribing, dispensing and administration of medicines, automating the handling of medicines in the supply chain, and providing tools for monitoring the efficacy and safety of medicines in use. Further advances will enable pharmacists to interact with patients through the creation of a common platform for accessing data and information in new, more efficient way.